Propanc Biopharma PPCB 深 滬
等待開盤 08-20 09:30:00 美东时间
3.67
-2.180
-37.26%
華盛通- 最 高4.9833
- 今 開4.84
- 成交量 244.13万股
- 最 低 3.51
- 昨 收 5.85
- 總市值 4261.53万
- 52周最高 4.9833
- 市盈率 靜 --
- 換手率 21.02%
- 52周最低 0.00
- 委 比 72.22%
- 總股本 1161.18万
- 歷史最高 4.9833
- 量 比 0
- 振 幅 25.18%
- 歷史最低 0.00
- 每 手 1
- 風險率 3.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Propanc Biopharma closes public offering, uplists to NASDAQ
Propanc Biopharma (NASDAQ:PPCB) on Tuesday said that it closed an underwritten public offering of 1,000,000 shares of its common stock, at $4.00 per share for gross proceeds of $4M. Shares began tradi...
今天 01:04
What's Going On With Propanc Shares Monday?
Propanc Biopharma shares are trading higher Monday. The company recently priced a $4 million public offering and began trading on the Nasdaq Capital Market.
08-19 01:57
Why Is Propanc Biopharma Stock (PPCB) Up 150% Today?
Propanc Biopharma stock was up on Monday alongside an uplisting and public offe...
08-18 19:44
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Shares of Dayforce Inc (NYSE:DAY) rose sharply in pre-market trading. Bloomberg...
08-18 18:51
一周IPO观察：中慧生物/银诺医药大涨，双登股份招股，奥克斯过讯，Bullish美股上市，Gemini递表
港股IPO观察 截止2025年的第33周，港交所2家上市，1家招股，3家聆讯，8家递表。 当周上市（2家） 研发流感疫苗的生物医药公司 $中慧生物-B(02...
08-18 12:02
美股机会日报丨“恐怖数据”符合预期，交易员下调美联储降息预期；巴菲特Q2新建仓股飙升，联合健康盘前涨超10%
“恐怖数据”符合预期，交易员下调美联储降息预期；巴菲特Q2新建仓股盘前飙升，联合健康涨超10%，纽柯钢铁涨近5%；美俄首脑即将举行会晤>>
08-15 20:49
Propanc Biopharma prices $4M stock offering
Propanc Biopharma (OTCPK:PPCB) priced a public offering of 1M shares at $4 each, expecting $4M in gross proceeds to fund working capital and general purposes. In connection with the offering, the comp...
08-15 16:11
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
Propanc Biopharma, a biopharmaceutical company developing novel cancer treatments, announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $4.00 per share, expected to yield approximately $4 million in gross proceeds. The company plans to use the proceeds for working capital and general business purposes. Propanc also granted the underwriter a 45-day option to purchase up to 150,000 additional shares. T...
08-15 03:00
Propanc Biopharma Appoints New Chief Financial Officer
Propanc Biopharma ( ($PPCB) ) has shared an announcement. On August 13, 2025, P...
08-14 05:29
Propanc Biopharma Enters Securities Purchase Agreement
Propanc Biopharma ( ($PPCB) ) has issued an announcement. On July 25, 2025, Pro...
07-31 05:13
